Paper3355415
The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
Flach AJ and 3 others. Arch Ophthalmol, 1988. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Papers, record 3355415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3355415
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aqueous Humor | Major topic |
| Capillary Permeability | Major topic |
| Cataract Extraction | Major topic |
| Dexamethasone | Major topic |
| Eye | Major topic |
| Pyrroles | Major topic |
| Tolmetin | Major topic |
| Tromethamine | Major topic |
| Adult | |
| Drug Combinations | |
| Female | |
| Fluorometry | |
| Humans | |
| Ketorolac Tromethamine | |
| Lenses, Intraocular | |
| Male | |
| Middle Aged | |
| Photometry | |
| Postoperative Period | |
| Solutions |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40007877 | Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, Pathogenesis, Risk Factors and Treatment. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/40007877 | PubMed |
| 38283484 | Macular Edema Following Silicone Oil Tamponade for Retinal Detachment: A Literature Review. | Cureus | 2023 | https://conductscience.org/library/papers/38283484 | PubMed |
| 27801522 | Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27801522 | PubMed |
| 24288446 | Inflammation and macular oedema after pars plana vitrectomy. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/24288446 | PubMed |
| 24227908 | Topical nonsteroidal anti-inflammatory drugs for macular edema. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/24227908 | PubMed |
| 23365785 | Nonsteroidal anti-inflammatory drugs for retinal disease. | Int J Inflam | 2013 | https://conductscience.org/library/papers/23365785 | PubMed |
| 22570544 | Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction. | Clin Ophthalmol | 2012 | https://conductscience.org/library/papers/22570544 | PubMed |
| 21750608 | Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery. | Clin Ophthalmol | 2011 | https://conductscience.org/library/papers/21750608 | PubMed |
| 19668551 | Diclofenac prevents temporal increase of intraocular pressure after uneventful cataract surgery with longer operation time. | Clin Ophthalmol | 2009 | https://conductscience.org/library/papers/19668551 | PubMed |
| 17285752 | Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note. | AAPS PharmSciTech | 2006 | https://conductscience.org/library/papers/17285752 | PubMed |
| 16354013 | In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note. | AAPS PharmSciTech | 2005 | https://conductscience.org/library/papers/16354013 | PubMed |
| 11820911 | Locally administered ocular corticosteroids: benefits and risks. | Drug Saf | 2002 | https://conductscience.org/library/papers/11820911 | PubMed |
| 10360304 | The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. | Trans Am Ophthalmol Soc | 1998 | https://conductscience.org/library/papers/10360304 | PubMed |
| 9290366 | Conventional routine clinical review may not be necessary after uncomplicated phacoemulsification. | Br J Ophthalmol | 1997 | https://conductscience.org/library/papers/9290366 | PubMed |
| 8703890 | Diffusion coefficient through the blood-aqueous barrier using a standard protocol. | Br J Ophthalmol | 1996 | https://conductscience.org/library/papers/8703890 | PubMed |
| 8695573 | The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. | Br J Ophthalmol | 1996 | https://conductscience.org/library/papers/8695573 | PubMed |
| 2178916 | Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. | Drugs | 1990 | https://conductscience.org/library/papers/2178916 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3355415
GET https://conductscience.org/api/papers/v1/3355415/authors